NASDAQ
Avalo Therapeutics, Inc. (AVTX) has a current ratio of 8.14x as of Monday, May 25, 2026. This represents a 27.01% increase compared to its 12-month average of 6.41x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.